Motohiro Fujiwara

38PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsLife historiesClinical pharmacology and therapeuticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Oct 07, 2026
Quantitative Evaluation of Pharmacologic Synergy for Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer: A Copula-Based Secondary Analysis.

|Aug 24, 2026
Multimodal artificial intelligence in prostate cancer: integrating multiparametric MRI with clinicopathological, molecular, and functional imaging data.

|Aug 22, 2026
A Bayesian reanalysis of the THOR trial cohort 1 using reconstructed individual patient data: interval-specific effects and clinically interpretable estimands under non-proportional hazards.

|Aug 19, 2026
Sex- and Age-Specific Trends in Prescriptions of Beta-3 Agonists and Anticholinergics in Japan: A Nationwide Prescription Database Study.

|Jun 30, 2026
Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101.

|Jun 26, 2026
Lateral Port-Site Hernia Following Robot-Assisted Radical Prostatectomy: Case Reports and Proposal of a Preventive Technique.

Pageof 7

Frequent Collaborators

18 joint publications

Hajime Tanaka

16 joint publications

Yasuhisa Fujii

10 joint publications

Soichiro Yoshida

9 joint publications

Yuma Waseda